معرفی
Michael Zachariadis is a Researcher at the Material and Chemical Characterisation (MC2) facility at the University of Bath, UK, where he contributes to interdisciplinary research in pharmaceutical nanotechnology, molecular cell biology, and advanced imaging. His work is aligned with the UN Sustainable Development Goals, particularly in health and well-being, through innovations in drug delivery and cancer therapy.
Research Interests: His expertise spans drug delivery systems, nanocarriers, photodynamic therapy, endoplasmic reticulum stress, and microRNA biology. He investigates novel formulations for targeted cancer treatment, including thermosensitive liposomes and silica-based nanocarriers for doxorubicin, as well as curcumin derivatives as photosensitizers. His work also explores the role of microRNAs in maintaining cellular homeostasis under stress.
Publication Trends: His recent publications (2020–2024) reflect a strong focus on nanomedicine and molecular therapeutics, combining materials science with biological applications. The research integrates fluorescence microscopy, confocal imaging, and in vitro models to evaluate therapeutic efficacy and cellular responses.
- Scientific Awards: No awards listed in available sources.
Advising and Grants: Michael Zachariadis serves as a Co-Investigator on the BBSRC-funded project Multi User High-Content Confocal Microscope (2022–2023), supporting advanced imaging capabilities for multiple research teams. While no formal students are listed, his collaborative publications suggest involvement in mentoring and team-based research.
Labs and Teams: He is embedded in the MC2 facility at the University of Bath, a central hub for materials and chemical analysis, and collaborates with a multidisciplinary team across biosciences and engineering departments.
